New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
United Therapeutics Corporation
UTHR
Shape
US Flag

NASDAQ

16B

Biotechnology

Next Earning date - 30 Oct 2024

16B

Biotechnology

Next Earning date - 30 Oct 2024

348.65USD
Shape-1.54 ( -0.44%)
favorite-chart

Relative Strenght

87
favorite-chart

Volume Buzz

-29%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

8%

Quote Panel

Shape
Updated October 27, 2024
1W -5.92 % 1M -2.71 % 3M 3.99 % 1Y 58.02 %

Key Metrics

Shape
  • Market Cap

    15.51B


  • Shares Outstanding

    44.49M


  • Share in Float

    43.71M


  • Dividende

    0


  • Earning Date

    30 Oct 2024


  • Price Target

    348.65


  • Average Volume

    411098


  • Beta

    0.569


  • Range

    208.62-377.03


  • Industry

    Biotechnology


  • Website

    https://www.unither.com


  • Sector

    Healthcare


Fundamentals

Shape

16.02x

P/E Ratio

5.93x

P/S Ratio

2.72x

P/B Ratio

0.1

Debt/Equity

40.9%

Net Margin

$21.8

EPS

How UTHR compares to sector?

P/E Ratio

Relative Strength

Shape

UTHR

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$3B

Shape332%

2025-Revenue

$27.18

Shape334%

2025-EPS

$1B

Shape236%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Morgan Stanley

downgrade

Previous: Overweight

2024-07-11

Now: Equal-Weight

Goldman Sachs

upgrade

Previous: Sell

2024-02-12

Now: Neutral

UBS

initialise

Previous: Not converted

2022-12-06

Now: Buy

Goldman Sachs

initialise

Previous: Not converted

2022-12-05

Now: Sell

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+44%

4.91
vs 3.42

Q4.22

arrow
arrow

+14%

2.67
vs 2.35

Q1.23

arrow
arrow

-3%

4.86
vs 5.03

Q2.23

arrow
arrow

+117%

5.24
vs 2.41

Q3.23

arrow
arrow

+10%

5.38
vs 4.91

Q4.23

arrow
arrow

+63%

4.36
vs 2.67

Q1.24

arrow
arrow

+27%

6.17
vs 4.86

Q2.24

arrow
arrow

+12%

5.85
vs 5.24

Q3.24

arrow
arrow

+21%

6.53
vs 5.38

Q4.24

arrow
arrow

+53%

6.69
vs 4.36

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+16%

516M  vs 444.7M

Q4.22

arrow
arrow

+18%

491.5M  vs 415.2M

Q1.23

arrow
arrow

+10%

506.9M  vs 461.9M

Q2.23

arrow
arrow

+28%

596.5M  vs 466.9M

Q3.23

arrow
arrow

+18%

609.4M  vs 516M

Q4.23

arrow
arrow

+25%

614.7M  vs 491.5M

Q1.24

arrow
arrow

+34%

677.7M  vs 506.9M

Q2.24

arrow
arrow

+20%

714.9M  vs 596.5M

Q3.24

arrow
arrow

+19%

723M  vs 609.4M

Q4.24

arrow
arrow

+19%

728.5M  vs 614.7M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+5%

0.05
vs 0.03

Q4.22

arrow
arrow

+3%

0.03
vs 0.05

Q1.23

arrow
arrow

+5%

0.05
vs 0.03

Q2.23

arrow
arrow

+5%

0.05
vs 0.05

Q3.23

arrow
arrow

+5%

0.05
vs 0.05

Q4.23

arrow
arrow

+4%

0.04
vs 0.05

Q1.24

arrow
arrow

+6%

0.06
vs 0.04

Q2.24

arrow
arrow

+5%

0.05
vs 0.06

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

471

471
vs 483

-2%

Q4.22

arrow
arrow

523

523
vs 471

11%

Q1.23

arrow
arrow

513

513
vs 523

-2%

Q2.23

arrow
arrow

484

484
vs 513

-6%

Q3.23

arrow
arrow

523

523
vs 484

8%

Q4.23

arrow
arrow

535

535
vs 523

2%

Q1.24

arrow
arrow

536

536
vs 535

0%

Q2.24

arrow
arrow

573

573
vs 536

7%

Earnings Growth

Latest News

UTHR

fxempire.com

12 hours ago